1-Piperidinecarboxylic acid,4-[[5-methyl-3-(1-methylethyl)pyrazolo[1,5-a]pyrimidin-7-yl]amino]-,1-[(2E)-4-(dimethylamino)-1-oxo-2-buten-1-yl]-3-pyrrolidinyl ester
95%
- Product Code: 201710
CAS:
2326428-25-3
| Molecular Weight: | 497.63 g./mol | Molecular Formula: | C₂₆H₃₉N₇O₃ |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | 1.27±0.1 g/cm3(Predicted) | Storage Condition: | -20°C, Sealed, Dry |
Product Description:
Used primarily in pharmaceutical research and development, this compound functions as a potent and selective inhibitor of Janus kinase 3 (JAK3), an enzyme involved in immune system signaling. Its main application lies in the treatment of autoimmune and inflammatory diseases such as rheumatoid arthritis, psoriasis, and inflammatory bowel disease. Due to its selectivity for JAK3 over other JAK family members, it offers potential for reduced side effects compared to broader JAK inhibitors. It is also investigated for use in organ transplantation to suppress immune rejection. The compound's structure allows for improved oral bioavailability and metabolic stability, making it suitable for once-daily dosing in clinical settings. Additionally, it serves as a valuable tool compound in biochemical assays to study JAK-STAT signaling pathways.
Sizes / Availability / Pricing:
| Size | Availability | Price | Quantity |
|---|---|---|---|
| 5mg | 10-20 days | ฿6,940.00 |
+
-
|
| 50mg | 10-20 days | ฿32,620.00 |
+
-
|
1-Piperidinecarboxylic acid,4-[[5-methyl-3-(1-methylethyl)pyrazolo[1,5-a]pyrimidin-7-yl]amino]-,1-[(2E)-4-(dimethylamino)-1-oxo-2-buten-1-yl]-3-pyrrolidinyl ester
Used primarily in pharmaceutical research and development, this compound functions as a potent and selective inhibitor of Janus kinase 3 (JAK3), an enzyme involved in immune system signaling. Its main application lies in the treatment of autoimmune and inflammatory diseases such as rheumatoid arthritis, psoriasis, and inflammatory bowel disease. Due to its selectivity for JAK3 over other JAK family members, it offers potential for reduced side effects compared to broader JAK inhibitors. It is also investigated for use in organ transplantation to suppress immune rejection. The compound's structure allows for improved oral bioavailability and metabolic stability, making it suitable for once-daily dosing in clinical settings. Additionally, it serves as a valuable tool compound in biochemical assays to study JAK-STAT signaling pathways.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :